SciELO - Scientific Electronic Library Online

vol.69 issue1Recomendaciones para la atención nutricional hospitalaria en pacientes con COVID-19. Revisión de la literaturaPriapism in a patient on hemodialysis and with COVID-19. Case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista de la Facultad de Medicina

Print version ISSN 0120-0011


ECHEVERRIA, Ronald Rainer; CACERES, Onice Jimena; QUINONES-LAVERIANO, Dante Manuel  and  SUEYOSHI, Jennifer Harumi. Cutaneous manifestations in a patient with COVID-19 treated at a hospital in the Peruvian jungle. A case report. [online]. 2021, vol.69, n.1, e600.  Epub May 17, 2021. ISSN 0120-0011.


Most patients infected with the coronavirus disease 2019 (COVID-19) experience mild to moderate symptoms. This condition may affect multiple organs and systems, including the skin, and cutaneous manifestations are varied. Although several studies on COVID-19 have been conducted in Peru, to date, this type of manifestation has not been described in the Peruvian population, especially in environments with high prevalence of viral diseases that cause similar dermatological lesions, such as the Peruvian jungle.

Case presentation:

A 16-year-old male patient with no relevant medical history was admitted to a hospital in the Peruvian jungle due to headache, chills, general malaise, and respiratory distress. On physical examination, oxygen saturation was 89-90%, and a skin rash was observed; it was characterized by non-evanescent, confluent, pruritic, and symmetrical morbilliform lesions in the limbs, abdomen, thorax, and face, without mucous membrane involvement. Due to the shortage of molecular tests in the region where he was treated, he was diagnosed with COVID-19 based on serological (serological tests for SARS-CoV-2 (IgM+ and IgG+)) and radiological criteria (imaging findings compatible with COVID-19 atypical pneumonia). The initial treatment included the administration of ceftriaxone, azithromycin, dexamethasone, cetirizine, as well as the use of oxygen by binasal cannula. After 5 days and given the persistence of symptoms and respiratory and skin signs, treatment with ivermectin was started. 48 hours after the introduction of this treatment, the cutaneous and respiratory manifestations had completely resolved.


Patients with COVID-19 may develop several cutaneous manifestations similar to those produced by other viruses or adverse drug reactions. Therefore, it is necessary to appropriately interview the patient and establish the chronological order of symptom onset to diagnose this disease correctly.

Keywords : COVID-19; Exanthema; Skin Manifestations (MeSH).

        · abstract in Spanish     · text in English     · English ( pdf )